Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intensive ketamine use for multiple years: A case report.

James X Liu1, Erin Zerbo, Stephen Ross

  • 1New York University School of Medicine, New York, New York.

The American Journal on Addictions
|April 1, 2015
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.

Nature. Mental health·2026
Same author

Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.

Psychedelic medicine (New Rochelle, N.Y.)·2026
Same author

The Effect of Chelated Trace Mineral Supplementation in the Form of Proteinates on Broiler Performance Parameters and Mineral Excretion: A Meta-Analysis.

Animals : an open access journal from MDPI·2025
Same author

Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion.

Research square·2025
Same author

Coverage with evidence development study shows benefits in patients with migraine treated with remote electrical neuromodulation.

The American journal of managed care·2025

This case study explores ketamine's potential for treating mood and addiction disorders. Despite daily high-dose use for five years, a patient experienced antidepressant effects and reduced alcohol cravings without withdrawal or cognitive deficits.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Ketamine is recognized for anesthetic properties.
  • Emerging evidence highlights ketamine's psychedelic and antidepressant effects.
  • Bipolar I disorder and substance dependence are complex conditions.

Observation:

  • A patient with bipolar I disorder and substance dependence used 1-3g of ketamine daily for 5 years.
  • The patient reported acute antidepressant effects and reduced alcohol cravings.
  • Ketamine use was unsustainable, leading to inpatient admission.

Findings:

  • Despite prolonged high-dose ketamine use, the patient showed no withdrawal syndrome upon cessation.
  • No observable cognitive deficits were noted after discontinuing ketamine.

Related Experiment Videos

  • This suggests a unique drug profile with potential therapeutic applications.

    • Implications:

    • Further research into ketamine's risks and benefits for mood disorders is warranted.
    • Ketamine's potential in treating addiction disorders warrants investigation.
    • This case highlights the need for personalized treatment strategies for complex psychiatric conditions.